Details for New Drug Application (NDA): 018551
✉ Email this page to a colleague
NDA 018551 describes POTASSIUM IODIDE, which is a drug marketed by Mission Pharmacal and Roxane and is included in two NDAs. It is available from one supplier. Additional details are available on the POTASSIUM IODIDE profile page.
The generic ingredient in POTASSIUM IODIDE is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
The generic ingredient in POTASSIUM IODIDE is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
Summary for 018551
| Tradename: | POTASSIUM IODIDE |
| Applicant: | Roxane |
| Ingredient: | potassium iodide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 1GM/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Feb 19, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
